Markus Feuerecker

Founding Partner & Managing Director, YZR Capital

📍 Germany🔄 Updated September 2026💼 12 investments📅 4 years investing🗓 Last invested Apr 2026
VC🌍 GermanyInvested this year
12
Total investments
4
Early stage
7
Mid stage
1
Late stage
4y
Years active

Portfolio

12 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Member
Apr 2026
dehaze is committed to uncover chronic diseases early enough to avoid negative quality of life impact on the patients. Our proprietary AI helps identifying overlooked diagnoses, inappropriate treatments and future health risks. We do this in a 3-step approach: (1) We unify and harmonize patient data into clean health trajectories. (2) We leverage our peer-reviewed AI model to identify outliers in the past trajectory and deviations in the future (3) We proactively share the insights with clinicians and patients alike to act promptly.
Board Member
Aug 2025
Doctor.One is a chronic care platform that empowers healthcare professionals to deliver continuous, asynchronous care — staying connected with their patients beyond the visit. We transform care into a relationship-driven experience, helping improve engagement, boost adherence, and reduce dropout in chronic treatment. Designed for healthcare systems, pharma partners, and care teams, Doctor.One increases clinical capacity, supports therapy outcomes, and ensures that no patient feels alone in their health journey. With a trusted care team just a message away, patients gain timely support and confidence, while professionals deliver smarter care with less effort. This is how we humanize medicine.
Board Member
Oct 2024
Biorce is a pioneering medtech company dedicated to revolutionizing drug development through the power of artificial intelligence (AI). We are passionate about accelerating medical advancements and improving patient outcomes. Our team comprises seasoned clinical research professionals, data scientists, and AI experts, working collaboratively to bridge the gap between cutting-edge technology and real-world clinical needs. With an unwavering commitment to revolutionize healthcare, Biorce envisions a world where all patients benefit from accelerated and cost-effective access to treatments. Our flagship product, Jarvis, stands as the pioneer Clinical AI assistant, granting universal access to clinical data at ones fingertips. Biorce is poised to redefine the landscape of healthcare, shaping a future where innovation and accessibility converge for the betterment of humanity. Join us in our mission to make a positive impact on healthcare. Learn more about our solutions and connect with our team on our LinkedIn page!
Board Member
Aug 2024
DeepLife is an early stage startup founded in 2019 by Jonathan Baptista and Jean-Baptiste Morlot, backed by international investors, developing the first SaaS platform for Digital Twin of cells. While we are able to design and build incredibly complex mechanical engines, engineering biological systems, such as cells, remains a challenge. However, recent technological improvements, notably in biochemistry, recently enabled the construction of databases with millions of quantitative cell activity measures, covering multiple diseases. The DeepLife team develops a SaaS platform combining state-of-the-art deep learning algorithms on multi-omics sequencing data, public and private cell atlases, and proprietary deep learning-based cell engineering tools. Our goal is to supplement in vitro testing with in silico simulations and rapidly discover molecular triggers to efficiently engineer cell behavior. We are working closely with biotech and pharmaceutical companies to accelerate their target identification processes. We are also collaborating actively with the academic community by publishing papers and providing open access to our platform’s features and data.
mid stageBiotechnology
Board Member
May 2024
Esper Bionics is a New York-based human augmentation startup building robotic limbs and controllers for people with limb differences.
Board Member
Feb 2024
Kalia Lab betreibt Kliniken für ästhetische Medizin, Hautpflege und Gesundheit mit modernsten Health-Tech-Standards. Wir bieten Kund*innen ein personalisiertes holistisches Konzept für äußere Schönheit und innere Gesundheit, unterstützt von modernsten digitalen Angeboten in der Patient Journey, und sind so hybride One-Stop-Destination für Beauty, Health & Skin Longevity. Unsere Treatments fokussieren natürliche und nachhaltige Ergebnisse, die durch unser Kalia Medical Concept, bei welchem wir nur die neuesten evidenzbasierten Behandlungs-Technologien einsetzen, ermöglicht und durch unsere Health-Tech-Infrastruktur unterstützt werden. Seit 2022 empfängt unsere Hamburger Klinik am Ballindamm Kund*innen, im Mai 2024 wird Berlin im neuen Quartier "Am Tacheles" eröffnen.
Board Member
Jan 2024
Deemea is a digital health company with expertise in the AI-driven structuring and analysis of medical data. Our specialization in imaging data processing has led us to develop and deploy a collaborative platform for medical data analysis, aimed at expediting biopharmaceutical and medical device clinical studies. Our innovative proprietary technology powers a multi-modal, multi-centric platform that prioritizes the security, privacy, and sovereignty of medical data, as well as the sustainability of healthcare facilities. Deemea empowers data-driven research, ultimately expediting patients access to innovative therapies.
Lead Investor
Oct 2023
We are a modern, fully digital metabolic health clinic. We focus on treating overweight and obesity through comprehensive diagnosis and groundbreaking therapies.
Board Member
Aug 2023
100+ million people globally suffer from vision-threatening retinal diseases. A $13bn drug can stop patients from vision loss. Still, ⅔ of cases of blindness in EU+US are due to these diseases like wet AMD. We provide an AI-based precision health platform that emulates a proven clinical method. This method used 2nd expert opinion for eye doctors to achieve 6x(!) better therapy results across thousands of patients: - Improving real-world vision outcomes by 3x (36% > 100%) - Keeping 2x more patients in therapy (38% > 78%) Our big vision is to prevent 1 million additional people from blindness by 2030 by empowering ophthalmologists with AI-based optimal therapy prognosis. Our pre-clinical AI is used by pharma, payors and providers’ associations to gain new insights on their therapy data. We work on our clinical product to provide therapy decision support with 1 click at the PoC in 2024.
Board Member
Jul 2023
Clare is an AI therapist available anytime, anywhere. Call or message Clare about anything on your mind, from worries and stress at work to sleep problems. Learn scientifically proven techniques to reflect, understand your feelings and improve your mental well-being. Theres no human, no judgment. Allowing you complete anonymity.
Board Member
Apr 2023
apoQlar medical is a forward-thinking medical software company dedicated to advancing healthcare through innovative virtual and mixed reality solutions. Founded with a commitment to enhancing diagnostic precision, medical training, pre-operative planning, and patient education, apoQlar medical has developed HoloMedicine® technology which empowers healthcare professionals to interact with 3D anatomical models, medical imaging, and simulated clinical scenarios in immersive virtual and mixed reality environments. Partnering with over 60 medical institutions worldwide, apoQlar medical designs technology that integrates seamlessly into clinical workflows, supporting both educators and clinicians in delivering higher quality, patient-centred care. Through continuous collaboration with medical professionals, apoQlar medical remains at the forefront of digital healthcare, ensuring that its solutions are both clinically relevant and grounded in evidence-based practices.
Investor
Feb 2022
Dbamy o supermoce Twoich pracowników! Docieramy z profilaktyką zdrowotną do biur, zakładów i domów. Organizujemy Akcje Zdrowia #uCiebie 👇 👉 Przeprowadzamy badania krwi tam, gdzie są Twoi pracownicy – bez kolejek, stresu i opóźnień. 👉 Nasz Opiekun Zdrowia zajmuje się całą organizacją i logistyką. 👉 Dobieramy badania do potrzeb zespołów – wypalenie zawodowe, cukrzyca, wegetarianizm? 👉 Uczestnicy mogą śledzić wyniki badań na intuicyjnym dashboardzie i konsultować je ze specjalistami. 👉 Dostarczamy materiały edukacyjne – webinary, poradniki. 👉 Dla rodzin i przyjaciół pracowników oferujemy dodatkowe rabaty. 👉 Pomagamy w ewaluacji wydarzenia – ankiety, raporty, dane. 🤝 Zaufali nam m.in. Biedronka, PGE, Answear.com, Bridgestone, Znany Lekarz, Stalco, Cargotec Poland Sp. z o.o. Wielu klientów do nas wraca – na kolejne akcje i indywidualnie. Dlaczego warto? 💸 Oszczędności: Płacisz tylko za przeprowadzone badania – nawet -30% względem stawek rynkowych. 🙋‍♀️ Wysoka frekwencja: Nasze wydarzenia cieszą się niemal 100% udziałem pracowników. 🔄 Elastyczność: Organizujemy jednorazowe wydarzenia i cykliczne programy zdrowotne – wybierasz, co Ci pasuje. 📲 Bezpieczeństwo: Gwarantujemy bezpieczeństwo procedur medycznych i RODO. 🏅 Employer Branding: Po Akcji otrzymasz Certyfikat Zdrowa Firma, który wzmocni Twój wizerunek pracodawcy dbającego o zdrowie pracowników. Poznaj nas bliżej i zapytaj o Akcję Zdrowia #uCiebie w firmie 👉 https://akcjazdrowia.upacjenta.pl/
mid stagePublic Health
Experience · 16 entries
All (16)
Investments (12)
Board (10)
2026
Board Member
Apr 2026
dehaze is committed to uncover chronic diseases early enough to avoid negative quality of life impact on the patients. Our proprietary AI helps identifying overlooked diagnoses, inappropriate treatments and future health risks. We do this in a 3-step approach: (1) We unify and harmonize patient data into clean health trajectories. (2) We leverage our peer-reviewed AI model to identify outliers in the past trajectory and deviations in the future (3) We proactively share the insights with clinicians and patients alike to act promptly.
2025
Board Member
Aug 2025
Doctor.One is a chronic care platform that empowers healthcare professionals to deliver continuous, asynchronous care — staying connected with their patients beyond the visit. We transform care into a relationship-driven experience, helping improve engagement, boost adherence, and reduce dropout in chronic treatment. Designed for healthcare systems, pharma partners, and care teams, Doctor.One increases clinical capacity, supports therapy outcomes, and ensures that no patient feels alone in their health journey. With a trusted care team just a message away, patients gain timely support and confidence, while professionals deliver smarter care with less effort. This is how we humanize medicine.
2024
Board Member
Oct 2024
Biorce is a pioneering medtech company dedicated to revolutionizing drug development through the power of artificial intelligence (AI). We are passionate about accelerating medical advancements and improving patient outcomes. Our team comprises seasoned clinical research professionals, data scientists, and AI experts, working collaboratively to bridge the gap between cutting-edge technology and real-world clinical needs. With an unwavering commitment to revolutionize healthcare, Biorce envisions a world where all patients benefit from accelerated and cost-effective access to treatments. Our flagship product, Jarvis, stands as the pioneer Clinical AI assistant, granting universal access to clinical data at ones fingertips. Biorce is poised to redefine the landscape of healthcare, shaping a future where innovation and accessibility converge for the betterment of humanity. Join us in our mission to make a positive impact on healthcare. Learn more about our solutions and connect with our team on our LinkedIn page!
Board Member
Aug 2024
DeepLife is an early stage startup founded in 2019 by Jonathan Baptista and Jean-Baptiste Morlot, backed by international investors, developing the first SaaS platform for Digital Twin of cells. While we are able to design and build incredibly complex mechanical engines, engineering biological systems, such as cells, remains a challenge. However, recent technological improvements, notably in biochemistry, recently enabled the construction of databases with millions of quantitative cell activity measures, covering multiple diseases. The DeepLife team develops a SaaS platform combining state-of-the-art deep learning algorithms on multi-omics sequencing data, public and private cell atlases, and proprietary deep learning-based cell engineering tools. Our goal is to supplement in vitro testing with in silico simulations and rapidly discover molecular triggers to efficiently engineer cell behavior. We are working closely with biotech and pharmaceutical companies to accelerate their target identification processes. We are also collaborating actively with the academic community by publishing papers and providing open access to our platform’s features and data.
mid stageBiotechnology
Board Member
May 2024
Esper Bionics is a New York-based human augmentation startup building robotic limbs and controllers for people with limb differences.
Show all 16 entries ↓
Investment activity
2022–2026 · 12 investments
2022120234202452025120261
Recent (last 2 years)Earlier